Effect of Intravesical Resiniferatoxin (RTX) on Lower Urinary Tract Symptoms, Urodynamic Parameters, and Quality of Life of Patients with Urodynamic Increased Bladder Sensation

European Urology

Volumn 50, Issue 6, 2006, Pages 1299-1305

  Apostolidis, Apostolos ^a   Gonzales, Gwendoline E ^a   Fowler, Clare J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Hyperreflexia; Neurogenic; Overactive bladder; Resiniferatoxin; Urgency

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; RESINIFERATOXIN;

ADULT; AGED; ARTICLE; BLADDER CAPACITY; BLADDER DIARY; BLADDER DISCOMFORT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTALGIA; CYSTOMETRY; DETRUSOR MUSCLE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INFLAMMATION; INSTILLATION SITE IRRITATION; KING HEALTH QUESTIONNAIRE; MALE; MICTURITION; POLLAKISURIA; PRIORITY JOURNAL; QUALITY OF LIFE; URETHRA DISEASE; URETHRAL PAIN; URINARY TRACT INFECTION; URINARY URGENCY; URINE INCONTINENCE; URODYNAMICS;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; DITERPENES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROTOXINS; QUALITY OF LIFE; QUESTIONNAIRES; REFLEX, ABNORMAL; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; URODYNAMICS;

EID: 33750612399     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.04.006     Document Type: Article

References (31)

1. Silva C., Rio M.E., and Cruz F. Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia. Eur Urol 38 (2000) 444-452
2. Giannantoni A., Di Stasi S.M., Stephen R.L., et al. Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. J Urol 167 (2002) 1710-1714
3. Kuo H.C. Effectiveness of intravesical resiniferatoxin in treating detrusor hyper-reflexia and external sphincter dyssynergia in patients with chronic spinal cord lesions. BJU Int 92 (2003) 597-601
4. Kuo H.C. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions. J Urol 170 (2003) 835-839
5. Brady C.M., Apostolidis A., Harper M., et al. Parallel changes in bladder suburothelial vanilloid receptor TRPV1 (VR1) and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity (NDO) following intravesical resiniferatoxin treatment. BJU Int 93 (2004) 770-776
6. Silva C., Ribeiro M.J., and Cruz F. The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J Urol 168 (2002) 575-579
7. Yokoyama T., Nozaki K., Fujita O., Nose H., Inoue M., and Kumon H. Role of C afferent fibers and monitoring of intravesical resiniferatoxin therapy for patients with idiopathic detrusor overactivity. J Urol 172 (2004) 596-600
8. Silva C., Silva J., Ribeiro M.J., Avelino A., and Cruz F. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial. Eur Urol 48 (2005) 650-655
9. Kim J.H., Rivas D.A., Shenot P.J., et al. Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial. J Spinal Cord Med 26 (2003) 358-363
10. Dasgupta P., Chandiramani V.A., Beckett A., Scaravilli F., and Fowler C.J. The effect of intravesical capsaicin on the suburothelial innervation in patients with detrusor hyper-reflexia. BJU Int 85 (2000) 238-245
11. Brady C.M., Apostolidis A., Yiangou Y., et al. P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin. Eur Urol 46 (2004) 247-253
12. Smet P.J., Moore K.H., and Jonavicius J. Distribution and colocalization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder. Lab Invest 77 (1997) 37-49
13. Gillespie J.I. Inhibitory actions of calcitonin gene-related peptide and capsaicin: evidence for local axonal reflexes in the bladder wall. BJU Int 95 (2005) 149-156
14. Birder L.A., Nakamura Y., Kiss S., et al. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 5 (2002) 856-860
15. Cockayne D.A., Hamilton S.G., Zhu Q.-M., et al. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407 (2000) 1011-1015
16. Ferguson D.R., Kennedy I., and Burton T. ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes-a possible sensory mechanism?. J Physiol 505 (1997) 503-511
17. Yoshida M., Miyamae K., Iwashita H., Otani M., and Inadome A. Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging. Urology 63 (2004) 17-23
18. 3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin For human detrusor overactivity. J Urol 174 (2005) 977-983
19. Oliver S., Fowler C.J., Mundy A., and Craggs M. Measuring the sensations of urge and bladder filling during cystometry in urge incontinence and the effects of neuromodulation. Neurourol Urodyn 22 (2003) 7-16
20. Congregado Ruiz B., Pena Outeirino X.M., Campoy Martinez P., Leon Duenas E., and Leal Lopez A. Peripheral afferent nerve stimulation for treatment of lower urinary tract irritative symptoms. Eur Urol 45 (2004) 65-69
21. Lazzeri M., Beneforti P., Spinelli M., Zanollo A., Barbagli G., and Turini D. Intravesical resiniferatoxin for the treatment of hypersensitive disorder: a randomized placebo controlled study. J Urol 164 (2000) 676-679
22. Abrams P., Cardozo L., Fall M., et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21 (2002) 167-178
23. Payne C.K., Mosbaugh P.G., Forrest J.B., et al. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol 173 (2005) 1590-1594
24. Donovan J., Bosch R., Gotoh M., et al. Symptom and quality of life assessement. In: Abrams P., Cardozo L., Khoury S., and Wein A. (Eds). Incontinence (2005), Health Publications, Paris 519-584
25. Nordling J., Anjum F.H., Bade J.J., et al. Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol 45 (2004) 662-669
26. Avelino A., and Cruz F. Peptide immunoreactivity and ultrastructure of rat urinary bladder nerve fibers after topical desensitization by capsaicin or resiniferatoxin. Auton Neurosci 86 (2000) 37-46
27. Apostolidis A., Brady C.M., Yiangou Y., Davis J., Fowler C.J., and Anand P. Capsaicin receptor TRPV1 in the urothelium of neurogenic human bladders and the effect of intravesical resiniferatoxin. Urology 65 (2005) 400-405
28. Caterina M.J., Leffler A., Malmberg A.B., et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288 (2000) 306-313
29. Chapple C.R., and Wein A.J. The urgency of the problem and the problem of urgency in the overactive bladder. BJU Int 95 (2005) 274-275
30. Hashim H., and Abrams P. Is the bladder a reliable witness for predicting detrusor overactivity?. J Urol 175 (2006) 191-194 discussion 194-5
31. de Seze M., Wiart L., Joseph P.A., Dosque J.P., Mazaux J.M., and Barat M. Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn 17 (1998) 513-523